Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
BA ›
BAPREXIV
Trademark search for:
BAPREXIV
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-01-08 — Application filed
2015-01-12 — Application filed
2015-01-21 — Application filed
2015-03-06 — Assigned to examiner
2015-03-07 — Final disposition recorded
2015-03-07 — Final disposition recorded
2015-03-07 — Final disposition recorded
2015-06-11 — Office action issued
2015-06-11 — Correspondence received in law office
2015-06-12 — Teas/email correspondence entered
2015-06-14 — Approved for pub - principal register
2015-06-30 — Assigned to lie
2015-07-04 — Law office publication review completed
2015-07-22 — Notification of notice of publication e-mailed
2015-08-11 — Published for opposition
2015-08-11 — Official gazette publication confirmation e-mailed
2015-10-06 — Noa e-mailed - sou required from applicant
2016-03-09 — Sou teas extension received
2016-03-09 — Sou extension 1 filed
2016-03-09 — Sou extension 1 granted
2016-03-11 — Notice of approval of extension request e-mailed
2016-08-17 — Sou teas extension received
2016-08-17 — Sou extension 2 filed
2016-09-09 — Case assigned to intent to use paralegal
2016-09-12 — Sou extension 2 granted
2016-09-13 — Notice of approval of extension request e-mailed
2017-02-27 — Sou teas extension received
2017-02-27 — Sou extension 3 filed
2017-02-27 — Sou extension 3 granted
2017-03-01 — Notice of approval of extension request e-mailed
2017-09-07 — Sou teas extension received
2017-09-07 — Sou extension 4 granted
2017-09-07 — Sou extension 4 filed
2017-09-09 — Notice of approval of extension request e-mailed
2018-02-06 — Sou teas extension received
2018-02-06 — Sou extension 5 filed
2018-02-20 — Sou extension 5 granted
2018-02-21 — Notice of approval of extension request e-mailed
2018-11-12 — Application abandoned
2018-11-12 — Final status recorded
2018-11-13 — Application abandoned
Owner Information
Pfizer Inc.
New York , NY
Pfizer Inc.
New York , NY
Correspondent
KATRINA EDGE PFIZER INC. 235 E 42ND ST NEW YORK, NY 10017-5703 UNITED STATES
Filing Details
Filing Date:
2015-01-08
Status Date:
2018-11-12
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.